Mannkind (MNKD) Research & Development (2010 - 2026)
Mannkind (MNKD) reported Research & Development of $17.2 million for Q1 2026, up 56.33% year-over-year from $11.0 million in Q1 2025, and down 37.54% quarter-over-quarter from $27.6 million in Q4 2025.
Mannkind (MNKD) Research & Development (2010 - 2026) Analysis & Trends
Mannkind (MNKD) has 17 years of Research & Development data on file, last reported at $17.2 million in Q1 2026.
- Research & Development for Q1 2026 came in at $17.2 million, up 56.33% year-over-year; the trailing twelve-month figure through Mar 2026 was $72.6 million (up 54.7% YoY), and the FY2025 annual result was $66.3 million, up 44.57% from the prior year.
- Research & Development retreated to $17.2 million in Q1 2026 per MNKD's latest filing, from $27.6 million in the prior quarter.
- Over five years, Research & Development peaked at $27.6 million in Q4 2025 and troughed at $3.5 million in Q1 2022.
- A 5-year average of $10.6 million and a median of $10.0 million in 2024 frame the typical range for Research & Development.
- On a YoY basis, Research & Development climbed as much as 147.69% in 2025 and fell as far as 8.8% in 2025.
- A 5-year view of Research & Development shows it stood at $7.2 million in 2022, then grew by 29.07% to $9.2 million in 2023, then increased by 20.59% to $11.1 million in 2024, then surged by 147.69% to $27.6 million in 2025, then sank by 37.54% to $17.2 million in 2026.
- Business Quant data shows MNKD's Research & Development at $17.2 million in Q1 2026, $27.6 million in Q4 2025, and $14.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | -2.30 Mn |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 1.46 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | -58.00 Mn |
| 10 | Mannkind | 1.21 Bn | 1.08 Bn | 82.66 Mn | 17.23 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 17.23 Mn |
| Dec 31, 2025 | 27.59 Mn |
| Sep 30, 2025 | 14.06 Mn |
| Jun 30, 2025 | 13.68 Mn |
| Mar 31, 2025 | 11.02 Mn |
| Dec 31, 2024 | 11.14 Mn |
| Sep 30, 2024 | 12.93 Mn |
| Jun 30, 2024 | 11.82 Mn |
| Mar 31, 2024 | 10.01 Mn |
| Dec 31, 2023 | 9.24 Mn |
| Sep 30, 2023 | 9.99 Mn |
| Jun 30, 2023 | 6.45 Mn |
| Mar 31, 2023 | 5.61 Mn |
| Dec 31, 2022 | 7.16 Mn |
| Sep 30, 2022 | 4.14 Mn |
| Jun 30, 2022 | 4.89 Mn |
| Mar 31, 2022 | 3.54 Mn |
| Dec 31, 2021 | 3.89 Mn |
| Sep 30, 2021 | 3.66 Mn |
| Jun 30, 2021 | 2.33 Mn |